We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.39%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$16.4B
AUM Growth
+$115M
(+0.71%)
Cap. Flow
-$311M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
1,564
New
34
Increased
207
Reduced
423
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$56.9M |
| 2 |
Gilead Sciences
GILD
|
+$46.6M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$45.7M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$43.4M |
| 5 |
Fortive
FTV
|
+$37.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$54.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$48M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$40.1M |
| 4 |
Danaher
DHR
|
+$37.7M |
| 5 |
American Water Works
AWK
|
+$32.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.81% |
| 2 | Healthcare | 13.76% |
| 3 | Industrials | 9.13% |
| 4 | Technology | 8.6% |
| 5 | Consumer Staples | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Molson Coors Class B
TAP
$7.68B
| $2M | 0.01% |
18,240
+2,740
| +18% | +$278K |
|
327
Vulcan Materials
VMC
$36.3B
| $1.99M | 0.01% |
17,500
-100
| -0.6% | -$11.8K |
|
|
BSTC
328
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.98M | 0.01% |
43,380
| – | – |
|
329
Dover
DOV
$27.2B
| $1.97M | 0.01% |
33,191
-27,421
| -45% | -$1.59M |
|
|
BBU
330
DELISTED
Brookfield Business Partners
BBU
| $1.97M | 0.01% |
116,755
-235,814
| -67% | -$3.3M |
|
|
MJN
331
DELISTED
Mead Johnson Nutrition Company
MJN
| $1.95M | 0.01% |
24,703
-2,394
| -9% | -$204K |
|
332
White Mountains Insurance
WTM
$5.47B
| $1.92M | 0.01% |
2,318
| – | – |
|
333
Stanley Black & Decker
SWK
$14.2B
| $1.9M | 0.01% |
15,415
| – | – |
|
|
CTWS
334
DELISTED
Connecticut Water Service Inc
CTWS
| $1.89M | 0.01% |
38,046
+3,740
| +11% | +$188K |
|
335
Mattel
MAT
$4.17B
| $1.88M | 0.01% |
62,209
-70
| -0.1% | -$2.29K |
|
336
GSK
GSK
$103B
| $1.87M | 0.01% |
34,772
-1,541
| -4% | -$84.5K |
|
|
TIF
337
DELISTED
Tiffany & Co.
TIF
| $1.87M | 0.01% |
25,728
-325
| -1% | -$21.7K |
|
338
Realty Income
O
$61.2B
| $1.86M | 0.01% |
28,619
+8,643
| +43% | +$571K |
|
|
ESGR
339
DELISTED
Enstar Group
ESGR
| $1.85M | 0.01% |
11,277
-5,550
| -33% | -$913K |
|
340
Smith & Wesson
SWBI
$655M
| $1.8M | 0.01% |
88,193
+3,446
| +4% | +$75.4K |
|
341
Onto Innovation
ONTO
$13.6B
| $1.8M | 0.01% |
80,400
-300
| -0.4% | -$6.29K |
|
342
Ralph Lauren
RL
$22.2B
| $1.79M | 0.01% |
17,725
-4,000
| -18% | -$402K |
|
|
SGBK
343
DELISTED
Stonegate Bank
SGBK
| $1.79M | 0.01% |
53,043
| – | – |
|
|
HES
344
DELISTED
Hess
HES
| $1.79M | 0.01% |
33,328
| – | – |
|
345
DuPont de Nemours
DD
$18.6B
| $1.76M | 0.01% |
13,409
-98
| -0.7% | -$13.1K |
|
|
WGL
346
DELISTED
Wgl Holdings
WGL
| $1.72M | 0.01% |
27,500
-550
| -2% | -$36.6K |
|
347
RenaissanceRe
RNR
$13.8B
| $1.7M | 0.01% |
14,142
-6,200
| -30% | -$731K |
|
348
CME Group
CME
$92.2B
| $1.7M | 0.01% |
16,230
| – | – |
|
349
Boeing
BA
$165B
| $1.65M | 0.01% |
12,509
+48
| +0.4% | +$6.32K |
|
|
FARM
350
DELISTED
Farmer Brothers
FARM
| $1.61M | 0.01% |
45,420
| – | – |
|
Similar funds
SAM
First Manhattan's Q3 2016 Portfolio in Review
As of Q3 2016, First Manhattan held 1,564 positions worth $16.4B, up 0.71% from $16.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
First Manhattan's Q3 2016 filing shows 34 new, 207 increased, 423 reduced and 108 closed positions. Its largest new stake was Fortive: 1,157,093 shares worth $37.1M. The largest sale was Viatris, an estimated $54.4M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q3 2016 buy was Fortive: 1,157,093 shares worth $37.1M.
- First Manhattan added most to Abbott in Q3 2016, an estimated $56.9M increase.
- First Manhattan's biggest Q3 2016 reduction was Viatris, cutting an estimated $54.4M.
- First Manhattan fully exited ROUSE PPTYS INC COM (DE) in Q3 2016, selling an estimated $17.7M.
- First Manhattan's ten largest holdings make up 43% of its $16.4B portfolio in Q3 2016.
- First Manhattan opened 34 new positions and closed 108 in Q3 2016.
- First Manhattan's portfolio value rose 0.71% quarter-over-quarter to $16.4B.
Based on First Manhattan's 13F filing for Q3 2016, filed 20 Oct 2016.